|
1 |
|
 |
PrEP roll-out at the National Program in Brazil |
30.07.2018 - 17:34 |
|
|
2 |
|
 |
Main adverse reactions motivating the substitution of Dolutegravir in Antiretroviral Therapy regimens in Brazil |
31.07.2018 - 10:39 |
|
|
3 |
|
 |
How it was possible to offer Integrase Inhibitor as first line ART while maintaining the sustainability of the Brazilian policy of universal access to drugs |
31.07.2018 - 10:36 |
|
|
4 |
|
 |
Combination Prevention among young people from key populations: a Brazilian experience through peer-to-peer education |
26.07.2018 - 17:53 |
|
|
5 |
|
 |
Virological monitoring of the switch from RAL-containing to DTG-containing regimens in Brazil: data from a real-world cohort |
31.07.2018 - 10:37 |
|
|
6 |
|
 |
User profiles, regimen choices and types of exposure in HIV post-exposure prophylaxis before and after after the implementation of guidelines in Brazil |
26.07.2018 - 17:53 |
|
|
7 |
|
 |
Factors associated with adherence to antiretroviral therapy in Brazil in 2017 |
26.07.2018 - 17:53 |
|
|
8 |
|
 |
Clinical monitoring system for people living with HIV (SIMC) and continuum care improvement in Brazilian Brazil |
26.07.2018 - 17:53 |
|
|
9 |
|
 |
Dating app and HIV - making possible an international partnership within the Brazilian government |
26.07.2018 - 17:53 |
|
|
10 |
|
 |
Distance learning course about rapid test for healthcare professionals as an strategy to increase the access to HIV diagnosis in Brazil |
31.07.2018 - 10:37 |
|
|
11 |
|
 |
Brazilian e-health strategy for expanding, strengthening and monitoring ART adherence |
26.07.2018 - 17:53 |
|
|
12 |
|
 |
A dating app to prevent HIV: a Brazilian e-health project with and for young gay people |
25.07.2018 - 09:49 |
|